Literature DB >> 16946502

Protective effects of breviscapine on ischemic vascular dementia in rats.

Zhe Xiong1, Chao Liu, Fang Wang, Cailian Li, Wei Wang, Jianzhi Wang, Jianguo Chen.   

Abstract

Breviscapine, a traditional Chinese medicine, is extensively used in clinic to treat cardiovascular diseases and cerebrovascular injury. In this study, we demonstrated the effects of breviscapine on vascular dementia (VD) rats, which were mimicked by permanent occlusion of bilateral common carotid arteries. Breviscapine (2 mg/kg for 14 d) improved the performance of learning and memory of VD rats in Morris water maze, decreased the level of lipid peroxidation and free radicals, and attenuated the pathological alterations, such as nuclear shrink, cellular edema and irregular arrangement of pyramidal layer in the hippocampal CA(1) area. In vitro experiment, breviscapine (50 microg/l) protected cortical neuron from injury and decreased intracellular calcium overloading induced by H2O2 (10 mM). The results suggest that breviscapine has therapeutic effect on cerebral ischemia and vascular dementia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16946502     DOI: 10.1248/bpb.29.1880

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Scutellarin protects against Aβ-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase.

Authors:  Li-li Guo; Zhi-zhong Guan; Yong-lin Wang
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

2.  Sinomenine protects against ischaemic brain injury: involvement of co-inhibition of acid-sensing ion channel 1a and L-type calcium channels.

Authors:  Wen-Ning Wu; Peng-Fei Wu; Xiang-Long Chen; Zui Zhang; Jun Gu; Yuan-Jian Yang; Qiu-Ju Xiong; Lan Ni; Fang Wang; Jian-Guo Chen
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 3.  Medicinal Herbs and Their Derived Ingredients Protect against Cognitive Decline in In Vivo Models of Alzheimer's Disease.

Authors:  Yueh-Ting Tsai; Shung-Te Kao; Chin-Yi Cheng
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

4.  Scutellarin attenuates hypertension-induced expression of brain Toll-like receptor 4/nuclear factor kappa B.

Authors:  Xingyong Chen; Xiaogeng Shi; Xu Zhang; Huixin Lei; Simei Long; Huanxing Su; Zhong Pei; Ruxun Huang
Journal:  Mediators Inflamm       Date:  2013-09-25       Impact factor: 4.711

5.  Neuroprotective effects of tetrandrine against vascular dementia.

Authors:  Yan-Ling Lv; Ze-Zhi Wu; Li-Xue Chen; Bai-Xue Wu; Lian-Lian Chen; Guang-Cheng Qin; Bei Gui; Ji-Ying Zhou
Journal:  Neural Regen Res       Date:  2016-03       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.